Guideline report demonstrates updated diagnostic and therapeutic strategies in patients with rhinosinusitis, highlighting modernized evidence-based standards worldwide.
The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common, yet burdensome condition is diagnosed and treated around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clear recommendations based on all available evidence.
No takes yet. Share an insight, caveat, or question.
Fokkens et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: